Literature DB >> 2773986

Clinical, cytogenetic, and pedigree findings in 18 cases of Aicardi syndrome.

A E Donnenfeld1, R J Packer, E H Zackai, C M Chee, B Sellinger, B S Emanuel.   

Abstract

Eighteen girls with Aicardi syndrome were identified through a survey of neurologists, geneticists, and ophthalmologists. All had infantile seizures, developmental delay, agenesis of the corpus callosum (complete: 72%, partial: 28%), and characteristic chorioretinal lacunar lesions. Costovertebral defects including hemivertebrae, scoliosis, and absent or malformed ribs were present in 39%, cortical heterotopias were present in 50%, and microphthalmia was identified in a third. Cytogenetic investigation was carried out in all families. An unbalanced X;3 translocation, 46,X,der(X)t(X;3)(p22.3;p23)mat, was discovered in a girl with chorioretinal lacunar lesions characteristic of Aicardi syndrome, developmental delay, and infantile seizures. However, this child had a normal appearing corpus callosum on CT and magnetic resonance imaging scans and therefore did not meet the criteria for inclusion in the study. Chromosomes of all other patients and parents were normal. Findings at birth, age of seizure onset, treatment, and prognosis are discussed. The pedigree data from these 18 families demonstrated an unaffected male:female sib ratio of 1:1.7 and a 14% spontaneous abortion rate. The findings of this study support the contention that Aicardi syndrome is an X-linked dominant disorder with early embryonic lethality in hemizygous males and that all cases represent new mutations.

Entities:  

Mesh:

Year:  1989        PMID: 2773986     DOI: 10.1002/ajmg.1320320405

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

Review 1.  X linked mental retardation.

Authors:  I A Glass
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

2.  Aicardi syndrome associated with autosomal genomic imbalance: coincidence or evidence for autosomal inheritance with sex-limited expression?

Authors:  P Prontera; A Bartocci; V Ottaviani; I Isidori; D Rogaia; C Ardisia; G Guercini; A Mencarelli; E Donti
Journal:  Mol Syndromol       Date:  2013-04-11

3.  Laterality of brain and ocular lesions in Aicardi syndrome.

Authors:  Michelle T Cabrera; Bryan J Winn; Travis Porco; Zoe Strominger; A James Barkovich; Creig S Hoyt; Mari Wakahiro; Elliott H Sherr
Journal:  Pediatr Neurol       Date:  2011-09       Impact factor: 3.372

4.  Aicardi syndrome: Neonatal diagnosis by means of transfontanellar ultrasound.

Authors:  Claudio Rodrigues Pires; E Araujo Júnior; Adriano Czapkowski; Sebastião Marques Zanforlin Filho
Journal:  World J Radiol       Date:  2014-07-28

Review 5.  Perinatal (fetal and neonatal) choroid plexus tumors: a review.

Authors:  John R Crawford; Hart Isaacs
Journal:  Childs Nerv Syst       Date:  2019-04-05       Impact factor: 1.475

6.  Role of ocular involvement in the prediction of visual development and clinical prognosis in Aicardi syndrome.

Authors:  A V Menezes; T L Lewis; J R Buncic
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

7.  Neuroimaging aspects of Aicardi syndrome.

Authors:  Bobbi Hopkins; V Reid Sutton; Richard Alan Lewis; Ignatia Van den Veyver; Gary Clark
Journal:  Am J Med Genet A       Date:  2008-11-15       Impact factor: 2.802

8.  A genome-wide screen for copy number alterations in Aicardi syndrome.

Authors:  Xiaoling Wang; V Reid Sutton; Tanya N Eble; Richard Alan Lewis; Preethi Gunaratne; Ankita Patel; Ignatia B Van den Veyver
Journal:  Am J Med Genet A       Date:  2009-10       Impact factor: 2.802

9.  Choroid plexus papilloma expansion over 7 years in Aicardi syndrome.

Authors:  Richard E Frye; Jon S Polling; Louis C K Ma
Journal:  J Child Neurol       Date:  2007-04       Impact factor: 1.987

10.  Palliative epilepsy surgery in Aicardi syndrome: a case series and review of literature.

Authors:  Aimen S Kasasbeh; Christina A Gurnett; Matthew D Smyth
Journal:  Childs Nerv Syst       Date:  2013-08-16       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.